These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22128078)

  • 1. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification.
    Verbruggen G; Wittoek R; Vander Cruyssen B; Elewaut D
    Ann Rheum Dis; 2012 Jun; 71(6):891-8. PubMed ID: 22128078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs.
    Verbruggen G; Goemaere S; Veys EM
    Clin Rheumatol; 2002 Jun; 21(3):231-43. PubMed ID: 12111630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbid anatomy of 'erosive osteoarthritis' of the interphalangeal finger joints: an optimised scoring system to monitor disease progression in affected joints.
    Verbruggen G; Wittoek R; Vander Cruyssen B; Elewaut D
    Ann Rheum Dis; 2010 May; 69(5):862-7. PubMed ID: 19948521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.
    Keystone EC; Kavanaugh AF; Sharp JT; Tannenbaum H; Hua Y; Teoh LS; Fischkoff SA; Chartash EK
    Arthritis Rheum; 2004 May; 50(5):1400-11. PubMed ID: 15146409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure.
    Møller Døhn U; Boonen A; Hetland ML; Hansen MS; Knudsen LS; Hansen A; Madsen OR; Hasselquist M; Møller JM; Østergaard M
    Ann Rheum Dis; 2009 Oct; 68(10):1585-90. PubMed ID: 19019887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trial.
    Aitken D; Laslett LL; Pan F; Haugen IK; Otahal P; Bellamy N; Bird P; Jones G
    Osteoarthritis Cartilage; 2018 Jul; 26(7):880-887. PubMed ID: 29499287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and radiological factors associated with erosive radiographic progression in hand osteoarthritis.
    Meersseman P; Van de Vyver C; Verbruggen G; Elewaut D; Wittoek R
    Osteoarthritis Cartilage; 2015 Dec; 23(12):2129-2133. PubMed ID: 26093212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study.
    Døhn UM; Ejbjerg B; Boonen A; Hetland ML; Hansen MS; Knudsen LS; Hansen A; Madsen OR; Hasselquist M; Møller JM; Ostergaard M
    Ann Rheum Dis; 2011 Feb; 70(2):252-8. PubMed ID: 20980282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between soft tissue swelling, joint space narrowing and erosive damage in hand X-rays of patients with rheumatoid arthritis.
    Kirwan J; Byron M; Watt I
    Rheumatology (Oxford); 2001 Mar; 40(3):297-301. PubMed ID: 11285377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study.
    Takeuchi T; Yamanaka H; Ishiguro N; Miyasaka N; Mukai M; Matsubara T; Uchida S; Akama H; Kupper H; Arora V; Tanaka Y
    Ann Rheum Dis; 2014 Mar; 73(3):536-43. PubMed ID: 23316080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: Potential utility of power doppler sonography in clinical practice.
    Fukae J; Isobe M; Kitano A; Henmi M; Sakamoto F; Narita A; Ito T; Mitsuzaki A; Shimizu M; Tanimura K; Matsuhashi M; Kamishima T; Atsumi T; Koike T
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1247-53. PubMed ID: 21671420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.
    Axelsen MB; Eshed I; Hørslev-Petersen K; Stengaard-Pedersen K; Hetland ML; Møller J; Junker P; Pødenphant J; Schlemmer A; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Krogh NS; Johansen JS; Østergaard M;
    Ann Rheum Dis; 2015 May; 74(5):867-75. PubMed ID: 24412895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years.
    Loef M; Kroon FPB; Bergstra SA; van der Pol JA; Lems WF; Kerstens PJSM; Allaart CF; Kloppenburg M
    Rheumatology (Oxford); 2018 Nov; 57(11):1917-1924. PubMed ID: 29471377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial.
    Mease PJ; Gladman DD; Ritchlin CT; Ruderman EM; Steinfeld SD; Choy EH; Sharp JT; Ory PA; Perdok RJ; Weinberg MA;
    Arthritis Rheum; 2005 Oct; 52(10):3279-89. PubMed ID: 16200601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis.
    Eder L; Thavaneswaran A; Chandran V; Gladman DD
    Ann Rheum Dis; 2014 Jun; 73(6):1007-11. PubMed ID: 23619157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands.
    Magnano MD; Chakravarty EF; Broudy C; Chung L; Kelman A; Hillygus J; Genovese MC
    J Rheumatol; 2007 Jun; 34(6):1323-7. PubMed ID: 17516620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
    van Herwaarden N; den Broeder AA; Jacobs W; van der Maas A; Bijlsma JW; van Vollenhoven RF; van den Bemt BJ
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010455. PubMed ID: 25264908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Influence of Disease Activity in Rheumatoid Arthritis on Radiographic Progression of Concomitant Interphalangeal Joint Osteoarthritis.
    Lechtenboehmer CA; Jaeger VK; Kyburz D; Walker UA; Hügle T
    Arthritis Rheumatol; 2019 Jan; 71(1):43-49. PubMed ID: 30073800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial.
    Ferrero S; Wittoek R; Allado E; Cruzel C; Fontas E; Breuil V; Ziegler L; Kremer J; Loeuille D; Roux CH
    Semin Arthritis Rheum; 2021 Aug; 51(4):831-838. PubMed ID: 34157578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
    Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
    Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.